Corrigendum: Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects

A Corrigendum on
Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects

by Huang, D., Wang, X., Zhu, Y., Gong, J., Liang, J., Song, Y., Zhang, Y., Liu, L., and Wei, C. (2021). Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects. Front. Pharmacol. 12:658,998. doi:10.3389/fphar.2021.658998

In the original article, there was a mistake in Table 1 as published. BZBS is a post-marketing drug, and there is an error in the components of BZBS and ratio amounts in application (Li et al., 2021). The corrected Table 1 appears below.

TABLE 1

TABLE 1. The ratio of the plants present in the preparation of BZBS.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Reference

Li, L., Chen, B., An, T., Zhang, H., Xia, B., Li, R., et al. (2021). BaZiBuShen Alleviates Altered Testicular Morphology and Spermatogenesis and Modulates Sirt6/P53 and Sirt6/NF-Κb Pathways in Aging Mice Induced by D-Galactose and NaNO2. J. Ethnopharmacol 271, 113810. doi:10.1016/j.jep.2021.113810

CrossRef Full Text | Google Scholar